- Home
- EEA vs SRTS Comparison
EEA vs SRTS Comparison
Compare EEA & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEA
- SRTS
- Stock Information
- Founded
- EEA 1986
- SRTS 2010
- Country
- EEA Germany
- SRTS United States
- Employees
- EEA N/A
- SRTS N/A
- Industry
- EEA Trusts Except Educational Religious and Charitable
- SRTS Medical/Dental Instruments
- Sector
- EEA Finance
- SRTS Health Care
- Exchange
- EEA Nasdaq
- SRTS Nasdaq
- Market Cap
- EEA 67.9M
- SRTS 75.5M
- IPO Year
- EEA N/A
- SRTS 2016
- Fundamental
- Price
- EEA $10.68
- SRTS $3.35
- Analyst Decision
- EEA
- SRTS Strong Buy
- Analyst Count
- EEA 0
- SRTS 3
- Target Price
- EEA N/A
- SRTS $8.00
- AVG Volume (30 Days)
- EEA 9.2K
- SRTS 244.9K
- Earning Date
- EEA 01-01-0001
- SRTS 08-07-2025
- Dividend Yield
- EEA 1.92%
- SRTS N/A
- EPS Growth
- EEA N/A
- SRTS N/A
- EPS
- EEA N/A
- SRTS N/A
- Revenue
- EEA N/A
- SRTS $37,564,000.00
- Revenue This Year
- EEA N/A
- SRTS $4.33
- Revenue Next Year
- EEA N/A
- SRTS $26.74
- P/E Ratio
- EEA N/A
- SRTS N/A
- Revenue Growth
- EEA N/A
- SRTS 3.29
- 52 Week Low
- EEA $7.45
- SRTS $3.03
- 52 Week High
- EEA $9.26
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- EEA 71.63
- SRTS 31.02
- Support Level
- EEA $10.33
- SRTS $3.03
- Resistance Level
- EEA $10.40
- SRTS $3.45
- Average True Range (ATR)
- EEA 0.15
- SRTS 0.32
- MACD
- EEA 0.04
- SRTS -0.23
- Stochastic Oscillator
- EEA 87.84
- SRTS 11.07
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.